Matches in Wikidata for { <http://www.wikidata.org/entity/Q66033403> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q66033403 description "clinical trial" @default.
- Q66033403 description "ensayu clínicu" @default.
- Q66033403 description "klinisch onderzoek" @default.
- Q66033403 description "клінічне випробування" @default.
- Q66033403 name "Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer" @default.
- Q66033403 name "Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer" @default.
- Q66033403 type Item @default.
- Q66033403 label "Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer" @default.
- Q66033403 label "Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer" @default.
- Q66033403 prefLabel "Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer" @default.
- Q66033403 prefLabel "Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer" @default.
- Q66033403 P1132 Q66033403-E71A6F71-ACC3-458A-BFF8-E0371358AAA0 @default.
- Q66033403 P1476 Q66033403-AA7FAD31-8E59-4B32-ABC0-A6B444A4D602 @default.
- Q66033403 P17 Q66033403-378445E3-537E-423A-88AB-18748E5874B2 @default.
- Q66033403 P3098 Q66033403-4C47CE38-3FDE-424B-9086-CCB256F78067 @default.
- Q66033403 P31 Q66033403-C450BE13-83CF-4C75-BBAB-B8FD3A5418CF @default.
- Q66033403 P4844 Q66033403-E26C665B-1CD3-4242-A257-FE1EDCBAB3F4 @default.
- Q66033403 P4844 Q66033403-FEBE4C84-5F5C-4DBB-81F7-57ABCC5F91EA @default.
- Q66033403 P580 Q66033403-9816B8C1-4B05-43EF-9DC2-4F9A6056F522 @default.
- Q66033403 P582 Q66033403-8D4EBCD1-7555-40DB-8E4F-E872FB483148 @default.
- Q66033403 P6099 Q66033403-F24EB3A2-08FD-459A-8080-26216A637411 @default.
- Q66033403 P6153 Q66033403-17C6C176-69AC-40E6-932C-1423616E92DC @default.
- Q66033403 P6153 Q66033403-416181E6-475C-4A1E-BD09-AB0CFD554BD6 @default.
- Q66033403 P6153 Q66033403-434880C2-12B4-41AD-90DC-8770A12061D0 @default.
- Q66033403 P6153 Q66033403-725DA847-4754-4DAB-8993-A90E42225853 @default.
- Q66033403 P6153 Q66033403-72A99BC0-E1A0-4C4E-BA68-9641CE00FEEE @default.
- Q66033403 P6153 Q66033403-9A0D29BF-CD2B-4D79-8D3C-1D0512C4A28B @default.
- Q66033403 P6153 Q66033403-AAE7C150-28F9-4A8C-95D7-1725BEB33E48 @default.
- Q66033403 P6153 Q66033403-BC3B0B8C-DB0B-419E-950E-1C37F46B8D38 @default.
- Q66033403 P6153 Q66033403-C12F5353-5E19-47BD-B17F-0E0E44AA2C1E @default.
- Q66033403 P6153 Q66033403-DEB3E8C8-7F26-4CA8-BDD0-A5FA6BE63263 @default.
- Q66033403 P6153 Q66033403-DFC4E024-CDB0-4883-A888-5239EB4CD855 @default.
- Q66033403 P8363 Q66033403-682BACDE-D883-4388-BDBE-F83A10F99B62 @default.
- Q66033403 P859 Q66033403-EA386F7C-22A6-48A4-BBF2-4AFA34B4D346 @default.
- Q66033403 P1132 "+470" @default.
- Q66033403 P1476 "A PHASE III RANDOMIZED STUDY OF CISPLATIN (NSC #119875) AND TAXOL (PACLITAXEL) (NSC #125973) WITH INTERVAL SECONDARY CYTOREDUCTION VERSUS CISPLATIN AND PACLITAXEL IN PATIENTS WITH SUBOPTIMAL STAGE III & IV EPITHELIAL OVARIAN CARCINOMA" @default.
- Q66033403 P17 Q30 @default.
- Q66033403 P3098 "NCT00002568" @default.
- Q66033403 P31 Q30612 @default.
- Q66033403 P4844 Q412415 @default.
- Q66033403 P4844 Q423762 @default.
- Q66033403 P580 "1994-06-01T00:00:00Z" @default.
- Q66033403 P582 "2004-12-01T00:00:00Z" @default.
- Q66033403 P6099 Q42824827 @default.
- Q66033403 P6153 Q1047060 @default.
- Q66033403 P6153 Q1799872 @default.
- Q66033403 P6153 Q1808012 @default.
- Q66033403 P6153 Q45137223 @default.
- Q66033403 P6153 Q4858714 @default.
- Q66033403 P6153 Q5476635 @default.
- Q66033403 P6153 Q640652 @default.
- Q66033403 P6153 Q6806451 @default.
- Q66033403 P6153 Q6914126 @default.
- Q66033403 P6153 Q7895818 @default.
- Q66033403 P6153 Q7972509 @default.
- Q66033403 P8363 Q78089383 @default.
- Q66033403 P859 Q5625184 @default.